Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Chevron (CVX) Stock on December 3, 2025: New $19 Billion Capex Plan, Syria Talks and HSBC Upgrade Reset the Outlook

Chevron (CVX) Stock on December 3, 2025: New $19 Billion Capex Plan, Syria Talks and HSBC Upgrade Reset the Outlook

Chevron Corporation (NYSE: CVX) ended Wednesday, December 3, 2025, as one of the most closely watched energy stocks on Wall Street. The shares closed around $151.6, up just under 1% on the day, giving the U.S. oil major a market capitalization slightly above $300 billion. MarketBeat Behind that modest move is a dense cluster of fresh headlines: Here’s a detailed,…
Qualcomm (QCOM) Stock on December 3, 2025: AI Momentum, Hedge Fund Buying, Options Surge and Dividend Deadline

Qualcomm (QCOM) Stock on December 3, 2025: AI Momentum, Hedge Fund Buying, Options Surge and Dividend Deadline

Qualcomm Incorporated (NASDAQ: QCOM) is back in the spotlight as its stock climbs in early December, powered by an AI-heavy strategy, strong recent earnings, and a wave of institutional and options activity ahead of a key ex‑dividend date. As of the close on December 3, 2025, Qualcomm shares trade around $175 (about +2.5% on the day), leaving the stock roughly…
NXP Semiconductors (NXPI) Stock Jumps Again on December 3, 2025: Dividend Rush, AI Tailwinds and Auto Rebound Fuel Rally

NXP Semiconductors (NXPI) Stock Jumps Again on December 3, 2025: Dividend Rush, AI Tailwinds and Auto Rebound Fuel Rally

Published: December 3, 2025 – News & analysis, not investment advice. As of the close on December 3, 2025, NXP Semiconductors N.V. (NASDAQ: NXPI) finished at $227.56, up 5.7% on the day and roughly 14% over the last two sessions, after gains of 7.95% on Tuesday. StockAnalysis The move puts the Netherlands‑based chipmaker back near price levels last seen in…
Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (NYSE: CAH) stock has cooled off after a powerful run in 2025, raising a key question for investors: is this just a healthy pullback, or the start of something more serious? Below is a detailed, news-driven look at Cardinal Health’s share price, fundamentals, analyst forecasts and key risks as of December 3, 2025. Cardinal Health Stock Today: Five…
McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (NYSE: MCK) is ending 2025 as one of the standout performers in U.S. healthcare — but as of Wednesday, December 3, its stock is taking a breather. At the close, McKesson shares finished at $805.37, down 2.93% on the day and roughly 10% below their recent 52‑week high near $895, even after a powerful rally through most of…
Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

As of Wednesday, December 3, 2025, shares of The Home Depot, Inc. (NYSE: HD) closed at $357.91, up about 1.1% on the day, and roughly 18% below their 52‑week high of $436.36 set in December 2024. Trading volume was slightly above average, reflecting renewed interest after a turbulent November. MarketWatch That renewed interest isn’t random. Over the past few days…
Fiserv (FISV) Stock Jumps on Insider Buying as New Lawsuit and Black Friday Data Define a High-Risk 2025 Turnaround – December 3, 2025 Update

Fiserv (FISV) Stock Jumps on Insider Buying as New Lawsuit and Black Friday Data Define a High-Risk 2025 Turnaround – December 3, 2025 Update

Fiserv, Inc. (NASDAQ: FISV) squeezed out a rare rally on Wednesday, December 3, 2025, even as fresh legal action and mixed macro data kept the fintech giant’s turnaround story firmly in “show me” territory. At the close, Fiserv shares traded around $66.95, up nearly 6% on the day, after touching an intraday high of about $67.70. Volume topped 14.9 million…
Seagate (STX) Stock on December 3, 2025: Insider Selling, AI Tailwinds and Fresh Wall Street Price Targets

Seagate (STX) Stock on December 3, 2025: Insider Selling, AI Tailwinds and Fresh Wall Street Price Targets

Updated: December 3, 2025 Seagate Technology Holdings PLC (NASDAQ: STX) has been one of 2025’s standout AI infrastructure winners, but today’s trading shows just how volatile a high-flyer can be once expectations are sky‑high. On Wednesday, December 3, 2025, Seagate shares closed around $258.67, down roughly 3% on the day and marking a third straight session of losses, even as…
Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Published: December 3, 2025 – Information only, not investment advice. Mastercard stock on 3 December 2025: price and market snapshot As of the close on December 3, 2025, Mastercard Incorporated (NYSE: MA) is trading around $553.73 per share, modestly higher on the day and roughly mid‑range in its 52‑week band. Recent filings and price data show: Mastercard also pays a…
Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Data and prices in this article are as of the U.S. close on December 3, 2025. 1. Goldman Sachs stock today: price, valuation and performance The Goldman Sachs Group, Inc. (NYSE: GS) ended trading on December 3, 2025 around $836–837 per share, near its 52‑week high of $841.28. That gives the Wall Street bank a market capitalization of roughly $260…
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Published: December 3, 2025 Amgen Inc. (NASDAQ: AMGN) is closing out 2025 on a powerful upswing. As of the close on December 3, 2025, Amgen shares finished at $345.42, up about 2% on the day, and nudged higher in after-hours trading. StockAnalysis The move pushed the biotech giant to a fresh 52‑week high near $345.95, extending a year-to-date rally of…
Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

This article is for informational purposes only and does not constitute financial or legal advice. FCX Stock Today: Strong Rebound but Still Below Its Highs On Wednesday, December 3, 2025, Freeport-McMoRan Inc. (NYSE: FCX) closed at $44.53, up 3.63% on the day and comfortably ahead of the broader market, which also posted modest gains. Trading volume hit about 22.8 million…
1 734 735 736 737 738 812

Stock Market Today

  • Planet Labs (PL) Shares Surge Amid Overvaluation Concerns
    January 24, 2026, 11:40 PM EST. Planet Labs PBC (PL) has seen its share price surge 39.2% over 30 days, with a remarkable 395.2% gain over one year. Despite this strong performance, valuation metrics suggest caution. Simply Wall St's discounted cash flow (DCF) analysis estimates an intrinsic value of $2.11 per share, while the current price is over ten times that figure, indicating a potential overvaluation of 1179.1%. The stock has experienced volatility, including a recent 6.4% drop in the past week, reflecting mixed investor sentiment around its satellite-based Earth imaging business. Simply Wall St assigns a value score of 0 out of 6, highlighting red flags for prospective investors. These valuation concerns underline the importance of thorough analysis even amid impressive stock rallies.
Go toTop